Livingston, NJ, United States of America

Weichun Chen

USPTO Granted Patents = 2 


Average Co-Inventor Count = 8.2

ph-index = 1


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Weichun Chen: Innovator in Pharmaceutical Chemistry

Introduction

Weichun Chen is a notable inventor based in Livingston, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Weichun Chen holds 2 patents that showcase his innovative work. His latest patents include:

1. **Quinazolinone derivatives useful as vanilloid antagonists** - This patent describes a new polymorphic form of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and a method of preparing it.

2. **Niacin receptor agonists, compositions containing such compounds and methods of treatment** - This invention encompasses compounds of Formula (I), as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias, and similar conditions. Pharmaceutical compositions and methods of use are also included.

Career Highlights

Throughout his career, Weichun Chen has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Merck Sharp & Dohme Corporation. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Weichun Chen has collaborated with several professionals in his field, including Hong-Yong Kim and Jessica Liang. These collaborations have fostered innovation and the sharing of knowledge in pharmaceutical research.

Conclusion

Weichun Chen's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field and offers promising solutions for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…